ArticleFrontiers in medicine2023

Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging.

Natalia V Buchinskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.